Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Skin Cancer Diagnosis and Therapeutics Market Size Growth Rate by Type (2014-2025) 1.4.2 Actinic Keratoses (AK) 1.4.3 Based cell carcinoma (BCC) 1.4.4 Squamous cell carcinoma (SCC) 1.4.5 Melanoma 1.5 Market by Application 1.5.1 Global Skin Cancer Diagnosis and Therapeutics Market Share by Application (2014-2025) 1.5.2 Hospitals 1.5.3 Cancer research centers 1.5.4 Clinics 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Skin Cancer Diagnosis and Therapeutics Market Size 2.2 Skin Cancer Diagnosis and Therapeutics Growth Trends by Regions 2.2.1 Skin Cancer Diagnosis and Therapeutics Market Size by Regions (2014-2025) 2.2.2 Skin Cancer Diagnosis and Therapeutics Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Skin Cancer Diagnosis and Therapeutics Market Size by Manufacturers 3.1.1 Global Skin Cancer Diagnosis and Therapeutics Revenue by Manufacturers (2014-2019) 3.1.2 Global Skin Cancer Diagnosis and Therapeutics Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Skin Cancer Diagnosis and Therapeutics Market Concentration Ratio (CR5 and HHI) 3.2 Skin Cancer Diagnosis and Therapeutics Key Players Head office and Area Served 3.3 Key Players Skin Cancer Diagnosis and Therapeutics Product/Solution/Service 3.4 Date of Enter into Skin Cancer Diagnosis and Therapeutics Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Skin Cancer Diagnosis and Therapeutics Market Size by Type (2014-2019) 4.2 Global Skin Cancer Diagnosis and Therapeutics Market Size by Application (2014-2019) 5 United States 5.1 United States Skin Cancer Diagnosis and Therapeutics Market Size (2014-2019) 5.2 Skin Cancer Diagnosis and Therapeutics Key Players in United States 5.3 United States Skin Cancer Diagnosis and Therapeutics Market Size by Type 5.4 United States Skin Cancer Diagnosis and Therapeutics Market Size by Application 6 Europe 6.1 Europe Skin Cancer Diagnosis and Therapeutics Market Size (2014-2019) 6.2 Skin Cancer Diagnosis and Therapeutics Key Players in Europe 6.3 Europe Skin Cancer Diagnosis and Therapeutics Market Size by Type 6.4 Europe Skin Cancer Diagnosis and Therapeutics Market Size by Application 7 China 7.1 China Skin Cancer Diagnosis and Therapeutics Market Size (2014-2019) 7.2 Skin Cancer Diagnosis and Therapeutics Key Players in China 7.3 China Skin Cancer Diagnosis and Therapeutics Market Size by Type 7.4 China Skin Cancer Diagnosis and Therapeutics Market Size by Application 8 Japan 8.1 Japan Skin Cancer Diagnosis and Therapeutics Market Size (2014-2019) 8.2 Skin Cancer Diagnosis and Therapeutics Key Players in Japan 8.3 Japan Skin Cancer Diagnosis and Therapeutics Market Size by Type 8.4 Japan Skin Cancer Diagnosis and Therapeutics Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Skin Cancer Diagnosis and Therapeutics Market Size (2014-2019) 9.2 Skin Cancer Diagnosis and Therapeutics Key Players in Southeast Asia 9.3 Southeast Asia Skin Cancer Diagnosis and Therapeutics Market Size by Type 9.4 Southeast Asia Skin Cancer Diagnosis and Therapeutics Market Size by Application 10 India 10.1 India Skin Cancer Diagnosis and Therapeutics Market Size (2014-2019) 10.2 Skin Cancer Diagnosis and Therapeutics Key Players in India 10.3 India Skin Cancer Diagnosis and Therapeutics Market Size by Type 10.4 India Skin Cancer Diagnosis and Therapeutics Market Size by Application 11 Central & South America 11.1 Central & South America Skin Cancer Diagnosis and Therapeutics Market Size (2014-2019) 11.2 Skin Cancer Diagnosis and Therapeutics Key Players in Central & South America 11.3 Central & South America Skin Cancer Diagnosis and Therapeutics Market Size by Type 11.4 Central & South America Skin Cancer Diagnosis and Therapeutics Market Size by Application 12 International Players Profiles 12.1 Agilent 12.1.1 Agilent Company Details 12.1.2 Company Description and Business Overview 12.1.3 Skin Cancer Diagnosis and Therapeutics Introduction 12.1.4 Agilent Revenue in Skin Cancer Diagnosis and Therapeutics Business (2014-2019) 12.1.5 Agilent Recent Development 12.2 Amgen 12.2.1 Amgen Company Details 12.2.2 Company Description and Business Overview 12.2.3 Skin Cancer Diagnosis and Therapeutics Introduction 12.2.4 Amgen Revenue in Skin Cancer Diagnosis and Therapeutics Business (2014-2019) 12.2.5 Amgen Recent Development 12.3 Aqua Pharmaceuticals 12.3.1 Aqua Pharmaceuticals Company Details 12.3.2 Company Description and Business Overview 12.3.3 Skin Cancer Diagnosis and Therapeutics Introduction 12.3.4 Aqua Pharmaceuticals Revenue in Skin Cancer Diagnosis and Therapeutics Business (2014-2019) 12.3.5 Aqua Pharmaceuticals Recent Development 12.4 AstraZeneca 12.4.1 AstraZeneca Company Details 12.4.2 Company Description and Business Overview 12.4.3 Skin Cancer Diagnosis and Therapeutics Introduction 12.4.4 AstraZeneca Revenue in Skin Cancer Diagnosis and Therapeutics Business (2014-2019) 12.4.5 AstraZeneca Recent Development 12.5 Bristol-Myers Squibb 12.5.1 Bristol-Myers Squibb Company Details 12.5.2 Company Description and Business Overview 12.5.3 Skin Cancer Diagnosis and Therapeutics Introduction 12.5.4 Bristol-Myers Squibb Revenue in Skin Cancer Diagnosis and Therapeutics Business (2014-2019) 12.5.5 Bristol-Myers Squibb Recent Development 12.6 Daiichi Sankyo 12.6.1 Daiichi Sankyo Company Details 12.6.2 Company Description and Business Overview 12.6.3 Skin Cancer Diagnosis and Therapeutics Introduction 12.6.4 Daiichi Sankyo Revenue in Skin Cancer Diagnosis and Therapeutics Business (2014-2019) 12.6.5 Daiichi Sankyo Recent Development 12.7 Elekta 12.7.1 Elekta Company Details 12.7.2 Company Description and Business Overview 12.7.3 Skin Cancer Diagnosis and Therapeutics Introduction 12.7.4 Elekta Revenue in Skin Cancer Diagnosis and Therapeutics Business (2014-2019) 12.7.5 Elekta Recent Development 12.8 Eli Lilly 12.8.1 Eli Lilly Company Details 12.8.2 Company Description and Business Overview 12.8.3 Skin Cancer Diagnosis and Therapeutics Introduction 12.8.4 Eli Lilly Revenue in Skin Cancer Diagnosis and Therapeutics Business (2014-2019) 12.8.5 Eli Lilly Recent Development 12.9 Roche 12.9.1 Roche Company Details 12.9.2 Company Description and Business Overview 12.9.3 Skin Cancer Diagnosis and Therapeutics Introduction 12.9.4 Roche Revenue in Skin Cancer Diagnosis and Therapeutics Business (2014-2019) 12.9.5 Roche Recent Development 12.10 GSK 12.10.1 GSK Company Details 12.10.2 Company Description and Business Overview 12.10.3 Skin Cancer Diagnosis and Therapeutics Introduction 12.10.4 GSK Revenue in Skin Cancer Diagnosis and Therapeutics Business (2014-2019) 12.10.5 GSK Recent Development 12.11 iCAD 12.12 Bausch Health 12.13 Merck 12.14 Novartis 12.15 Pfizer 12.16 QIAGEN 12.17 Sanofi 12.18 Teva Pharmaceutical 12.19 Varian Medical Systems 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Skin Cancer Diagnosis and Therapeutics Key Market Segments Table Key Players Skin Cancer Diagnosis and Therapeutics Covered Table Global Skin Cancer Diagnosis and Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Skin Cancer Diagnosis and Therapeutics Market Size Market Share by Type 2014-2025 Figure Actinic Keratoses (AK) Figures Table Key Players of Actinic Keratoses (AK) Figure Based cell carcinoma (BCC) Figures Table Key Players of Based cell carcinoma (BCC) Figure Squamous cell carcinoma (SCC) Figures Table Key Players of Squamous cell carcinoma (SCC) Figure Melanoma Figures Table Key Players of Melanoma Table Global Skin Cancer Diagnosis and Therapeutics Market Size Growth by Application 2014-2025 (Million US$) Figure Hospitals Case Studies Figure Cancer research centers Case Studies Figure Clinics Case Studies Figure Skin Cancer Diagnosis and Therapeutics Report Years Considered Table Global Skin Cancer Diagnosis and Therapeutics Market Size 2014-2025 (Million US$) Figure Global Skin Cancer Diagnosis and Therapeutics Market Size and Growth Rate 2014-2025 (Million US$) Table Global Skin Cancer Diagnosis and Therapeutics Market Size by Regions 2014-2025 (Million US$) Table Global Skin Cancer Diagnosis and Therapeutics Market Size by Regions 2014-2019 (Million US$) Table Global Skin Cancer Diagnosis and Therapeutics Market Share by Regions 2014-2019 Figure Global Skin Cancer Diagnosis and Therapeutics Market Share by Regions 2014-2019 Figure Global Skin Cancer Diagnosis and Therapeutics Market Share by Regions 2019 Table Market Top Trends Table Global Skin Cancer Diagnosis and Therapeutics Revenue by Manufacturers (2014-2019) (Million US$) Table Global Skin Cancer Diagnosis and Therapeutics Market Share by Manufacturers (2014-2019) Figure Global Skin Cancer Diagnosis and Therapeutics Market Share by Manufacturers in 2018 Table Global Skin Cancer Diagnosis and Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Skin Cancer Diagnosis and Therapeutics Product/Solution/Service Table Date of Enter into Skin Cancer Diagnosis and Therapeutics Market Table Mergers & Acquisitions, Expansion Plans Table Global Skin Cancer Diagnosis and Therapeutics Market Size by Type (2014-2019) (Million US$) Table Global Skin Cancer Diagnosis and Therapeutics Market Size Share by Type (2014-2019) Figure Global Skin Cancer Diagnosis and Therapeutics Market Size Market Share by Type (2014-2019) Table Global Skin Cancer Diagnosis and Therapeutics Market Size by Application (2014-2019) (Million US$) Table Global Skin Cancer Diagnosis and Therapeutics Market Size Share by Application (2014-2019) Figure Global Skin Cancer Diagnosis and Therapeutics Market Size Market Share by Application (2014-2019) Figure Global Skin Cancer Diagnosis and Therapeutics Revenue Market Share by Application in 2018 Figure United States Skin Cancer Diagnosis and Therapeutics Market Size 2014-2019 (Million US$) Table United States Key Players Skin Cancer Diagnosis and Therapeutics Revenue (2018-2019) (Million US$) Table United States Key Players Skin Cancer Diagnosis and Therapeutics Market Share (2018-2019) Table United States Skin Cancer Diagnosis and Therapeutics Market Size by Type (2014-2019) (Million US$) Table United States Skin Cancer Diagnosis and Therapeutics Market Share by Type (2014-2019) Table United States Skin Cancer Diagnosis and Therapeutics Market Size by Application (2014-2019) (Million US$) Table United States Skin Cancer Diagnosis and Therapeutics Market Share by Application (2014-2019) Figure Europe Skin Cancer Diagnosis and Therapeutics Market Size 2014-2019 (Million US$) Table Europe Key Players Skin Cancer Diagnosis and Therapeutics Revenue (2018-2019) (Million US$) Table Europe Key Players Skin Cancer Diagnosis and Therapeutics Market Share (2018-2019) Table Europe Skin Cancer Diagnosis and Therapeutics Market Size by Type (2014-2019) (Million US$) Table Europe Skin Cancer Diagnosis and Therapeutics Market Share by Type (2014-2019) Table Europe Skin Cancer Diagnosis and Therapeutics Market Size by Application (2014-2019) (Million US$) Table Europe Skin Cancer Diagnosis and Therapeutics Market Share by Application (2014-2019) Figure China Skin Cancer Diagnosis and Therapeutics Market Size 2014-2019 (Million US$) Table China Key Players Skin Cancer Diagnosis and Therapeutics Revenue (2018-2019) (Million US$) Table China Key Players Skin Cancer Diagnosis and Therapeutics Market Share (2018-2019) Table China Skin Cancer Diagnosis and Therapeutics Market Size by Type (2014-20189) (Million US$) Table China Skin Cancer Diagnosis and Therapeutics Market Share by Type (2014-2019) Table China Skin Cancer Diagnosis and Therapeutics Market Size by Application (2014-2019) (Million US$) Table China Skin Cancer Diagnosis and Therapeutics Market Share by Application (2014-2019) Figure Japan Skin Cancer Diagnosis and Therapeutics Market Size 2014-2019 (Million US$) Table Japan Key Players Skin Cancer Diagnosis and Therapeutics Revenue (2018-2019) (Million US$) Table Japan Key Players Skin Cancer Diagnosis and Therapeutics Market Share (2018-2019) Table Japan Skin Cancer Diagnosis and Therapeutics Market Size by Type (2014-2019) (Million US$) Table Japan Skin Cancer Diagnosis and Therapeutics Market Share by Type (2014-2019) Table Japan Skin Cancer Diagnosis and Therapeutics Market Size by Application (2014-2019) (Million US$) Table Japan Skin Cancer Diagnosis and Therapeutics Market Share by Application (2014-2019) Figure Southeast Asia Skin Cancer Diagnosis and Therapeutics Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Skin Cancer Diagnosis and Therapeutics Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Skin Cancer Diagnosis and Therapeutics Market Share (2018-2019) Table Southeast Asia Skin Cancer Diagnosis and Therapeutics Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Skin Cancer Diagnosis and Therapeutics Market Share by Type (2014-2019) Table Southeast Asia Skin Cancer Diagnosis and Therapeutics Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Skin Cancer Diagnosis and Therapeutics Market Share by Application (2014-2019) Figure India Skin Cancer Diagnosis and Therapeutics Market Size 2014-2019 (Million US$) Table India Key Players Skin Cancer Diagnosis and Therapeutics Revenue (2018-2019) (Million US$) Table India Key Players Skin Cancer Diagnosis and Therapeutics Market Share (2018-2019) Table India Skin Cancer Diagnosis and Therapeutics Market Size by Type (2014-2019) (Million US$) Table India Skin Cancer Diagnosis and Therapeutics Market Share by Type (2014-2019) Table India Skin Cancer Diagnosis and Therapeutics Market Size by Application (2014-2019) (Million US$) Table India Skin Cancer Diagnosis and Therapeutics Market Share by Application (2014-2019) Figure Central & South America Skin Cancer Diagnosis and Therapeutics Market Size 2014-2019 (Million US$) Table Central & South America Key Players Skin Cancer Diagnosis and Therapeutics Revenue (2018-2019) (Million US$) Table Central & South America Key Players Skin Cancer Diagnosis and Therapeutics Market Share (2018-2019) Table Central & South America Skin Cancer Diagnosis and Therapeutics Market Size by Type (2014-2019) (Million US$) Table Central & South America Skin Cancer Diagnosis and Therapeutics Market Share by Type (2014-2019) Table Central & South America Skin Cancer Diagnosis and Therapeutics Market Size by Application (2014-2019) (Million US$) Table Central & South America Skin Cancer Diagnosis and Therapeutics Market Share by Application (2014-2019) Table Agilent Company Details Table Agilent Revenue in Skin Cancer Diagnosis and Therapeutics Business (2014-2019) (Million US$) Figure Agilent Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2014-2019) Table Agilent Recent Development Table Amgen Company Details Table Amgen Revenue in Skin Cancer Diagnosis and Therapeutics Business (2014-2019)(Million US$) Figure Amgen Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2014-2019) Table Amgen Recent Development Table Aqua Pharmaceuticals Company Details Table Aqua Pharmaceuticals Revenue in Skin Cancer Diagnosis and Therapeutics Business (2014-2019)(Million US$) Figure Aqua Pharmaceuticals Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2014-2019) Table Aqua Pharmaceuticals Recent Development Table AstraZeneca Company Details Table AstraZeneca Revenue in Skin Cancer Diagnosis and Therapeutics Business (2014-2019)(Million US$) Figure AstraZeneca Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2014-2019) Table AstraZeneca Recent Development Table Bristol-Myers Squibb Company Details Table Bristol-Myers Squibb Revenue in Skin Cancer Diagnosis and Therapeutics Business (2014-2019)(Million US$) Figure Bristol-Myers Squibb Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2014-2019) Table Bristol-Myers Squibb Recent Development Table Daiichi Sankyo Company Details Table Daiichi Sankyo Revenue in Skin Cancer Diagnosis and Therapeutics Business (2014-2019)(Million US$) Figure Daiichi Sankyo Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2014-2019) Table Daiichi Sankyo Recent Development Table Elekta Company Details Table Elekta Revenue in Skin Cancer Diagnosis and Therapeutics Business (2014-2019)(Million US$) Figure Elekta Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2014-2019) Table Elekta Recent Development Table Eli Lilly Company Details Table Eli Lilly Revenue in Skin Cancer Diagnosis and Therapeutics Business (2014-2019)(Million US$) Figure Eli Lilly Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2014-2019) Table Eli Lilly Recent Development Table Roche Company Details Table Roche Revenue in Skin Cancer Diagnosis and Therapeutics Business (2014-2019)(Million US$) Figure Roche Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2014-2019) Table Roche Recent Development Table GSK Company Details Table GSK Revenue in Skin Cancer Diagnosis and Therapeutics Business (2014-2019)(Million US$) Figure GSK Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2014-2019) Table GSK Recent Development Table iCAD Company Details Table Bausch Health Company Details Table Merck Company Details Table Novartis Company Details Table Pfizer Company Details Table QIAGEN Company Details Table Sanofi Company Details Table Teva Pharmaceutical Company Details Table Varian Medical Systems Company Details Table Global Skin Cancer Diagnosis and Therapeutics Market Size by Regions (Million US$) 2019-2025 Figure Global Skin Cancer Diagnosis and Therapeutics Market Size Share by Regions (2019-2025) Figure Global Skin Cancer Diagnosis and Therapeutics Market Size Share by Regions in 2025 Figure United States Skin Cancer Diagnosis and Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Europe Skin Cancer Diagnosis and Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure China Skin Cancer Diagnosis and Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Japan Skin Cancer Diagnosis and Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Skin Cancer Diagnosis and Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure India Skin Cancer Diagnosis and Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Skin Cancer Diagnosis and Therapeutics Market Size Forecast (2019-2025)(Million USD) Table Global Skin Cancer Diagnosis and Therapeutics Market Size by Product (2019-2025) (Million US$) Figure Global Skin Cancer Diagnosis and Therapeutics Market Size by Product (2019-2025) Figure Global Skin Cancer Diagnosis and Therapeutics Market Size by Product in 2025 Table Global Skin Cancer Diagnosis and Therapeutics Market Size by Application (2019-2025) (Million US$) Figure Global Skin Cancer Diagnosis and Therapeutics Market Size by Application (2019-2025) Figure Global Skin Cancer Diagnosis and Therapeutics Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Agilent Amgen Aqua Pharmaceuticals AstraZeneca Bristol-Myers Squibb Daiichi Sankyo Elekta Eli Lilly Roche GSK iCAD Bausch Health Merck Novartis Pfizer QIAGEN Sanofi Teva Pharmaceutical Varian Medical Systems